Association of age-related changes in circulating intermediary lipid metabolites, inflammatory and oxidative stress markers, and arterial stiffness in middle-Aged men

Age

Volumn 35, Issue 4, 2013, Pages 1507-1519

  Kim, Ji Young ^a,b   Kim, Oh Yoen ^c   Paik, Jean Kyung ^a   Kwon, Dae Young ^d   Kim, Hyun Jin ^d   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b Woosong University   (South Korea)

^c Dong A University   (South Korea)

^d Korea Food Research Institute   (South Korea)

Author keywords

Age related changes; Arterial stiffness; Inflammation; Intermediate metabolites; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARNITINE DERIVATIVE; CELL ADHESION MOLECULE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LINOLEYLCARNITINE; LIPID; LIPID PEROXIDE; LYSOPHOSPHATIDYLCHOLINE; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGING; ARTERIAL STIFFNESS; ARTICLE; BLOOD LEVEL; BRACHIAL ANKLE PULSE WAVE VELOCITY; CALORIC INTAKE; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; INFLAMMATION; LIPID PEROXIDATION; MALE; METABOLITE; METABOLITE BLOOD LEVEL; METABOLOMICS; MIDDLE AGED; NORMAL HUMAN; OXIDATIVE STRESS; PHENOTYPE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WAIST HIP RATIO; AGE; ANKLE BRACHIAL INDEX; BLOOD; BLOOD FLOW VELOCITY; CAROTID ARTERY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; LIPID METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; RETROSPECTIVE STUDY; SOUTH KOREA;

ADULT; AGE FACTORS; AGING; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CAROTID ARTERIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LIPID METABOLISM; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREVALENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; VASCULAR STIFFNESS; WAIST-HIP RATIO;

EID: 84891667863     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-012-9454-2     Document Type: Article

References (35)

1. Brinkley TE, Nicklas BJ, Kanaya AM, Satterfield S, Lakatta EG, Simonsick EM, Sutton-Tyrrell K, Kritchevsky SB (2009) Plasma oxidized low-density lipoprotein levels and arterial stiffness in older adults: the health, aging, and body composition study. Hypertension 53:846-852
2. Byfield FJ, Tikku S, Rothblat GH, Gooch KJ, Levitan I (2006) OxLDL increases endothelial stiffness, force generation, and network formation. J Lipid Res 47:715-723
3. Croset M, Brossard N, Polette A, Lagarde M (2000) Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J 345(Pt1):61-67
4. Dao HH, Essalihi R, Bouvet C, Moreau P (2005) Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 66:307-317
5. Fu C, Wang T, Wang Y, Chen X, Jiao J, Ma F, Zhong M, Bi K (2011) Metabonomics study of the protective effects of green tea polyphenols on aging rats induced by d-galactose. J Pharm Biomed Anal 55:1067-1074
6. Kampus P, Kals J, Ristimäe T, Muda P, Ulst K, Zilmer K, Salonen RM, Tuomainen TP, Teesalu R, Zilmer M (2007) Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein. J Hypertens 25:819-825
7. Kim JY, Park JY, Kim OY, Ham BM, Kim HJ, Kwon DY, Jang Y, Lee JH (2010a) Metabolic profiling of plasma in overweight/ obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-QTOF MS). J Proteome Res 9:4368-4375
8. Kim OY, Yoe HY, Kim HJ, Park JY, Kim JY, Lee SH, Lee JH, Lee KP, Jang Y, Lee JH (2010b) Independent inverse relationship between serum lycopene concentration and arterial stiffness. Atherosclerosis 208:581-586
9. Kougias P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C (2006) Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 12:RA5-RA16
10. Kume N, Cybulsky MI, Gimbrone MA Jr (1992) Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90:1138-1144
11. Lakatta EG, Levy D (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation 107:139-146
12. Lakatta EG (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation 107:490-497
13. Liu M, Subramanian VS, Subbaiah PV (1998) Modulation of the positional specificity of lecithin-cholesterol acyltransferase by the acyl group composition of its phosphatidylcholine substrate: role of the sn-1-Acyl group. Biochemistry 37:13626-13633
14. Liu-Wu Y, Hurt-Camejo E, Wiklund O (1998) Lysophosphatidylcholine induces the production of IL-1beta by human monocytes. Atherosclerosis 137:351-357
15. Loftus N, Miseki K, Iida J, Gika HG, Theodoridis G, Wilson ID (2008) Profiling and biomarker identification in plasma from different Zucker rat strains via high mass accuracy multistage mass spectrometric analysis using liquid chromatography/mass spectrometry with a quadrupole ion trap-time of flight mass spectrometer. Rapid Commun Mass Spectrom 22:2547-2554
16. Matsumoto T, Kobayashi T, Kamata K (2007) Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem 14:3209-3220
17. Murohara T, Scalia R, Lefer AM (1996) Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res 78:780-789
18. Nelson GT (1967) The phospholipid composition of plasma in various mammalian species. Lipids 2:323-328
19. Nevedomskaya E, Meissner A, Goraler S, de Waard M, Ridwan Y, Zondag G, van der Pluijm I, Deelder AM, Mayboroda OA (2010) Metabolic profiling of accelerated aging ERCC1 d/- mice. J Proteome Res 9:3680-3687
20. Ojala PJ, Hermansson M, Tolvanen M, Polvinen K, Hirvonen T, Impola U, Jauhiainen M, Somerharju P, Parkkinen J (2006) Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine. Biochemistry 45:14021-14031
21. O'Rourke MF, Hashimoto J (2007) Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 50:1-13
22. Rong JX, Berman JW, Taubman MB, Fisher EA (2002) Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 22:1617-1623
23. Scuteri A, Orru M, Morrell C, Piras MG, Taub D, Schlessinger D, Uda M, Lakatta EG (2011) Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study. Atherosclerosis 215:459-464
24. Stafforini DM, Sheller JR, Blackwell TS, Sapirstein A, Yull FE, McIntyre TM, Bonventre JV, Prescott SM, Roberts LJ 2nd (2006) Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-Activating factor acetylhydrolases. J Biol Chem 281:4616-4623
25. Steinbrecher UP, Pritchard PH (1989) Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by plateletactivating factor acetylhydrolase. J Lipid Res 30:305-315
26. TakabeW, Kanai Y, Chairoungdua A, ShibataN, Toi S,Kobayashi M, Kodama T, Noguchi N (2004) Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4 F2. Arterioscler Thromb Vasc Biol 24:1640-1645
27. Tomiyama H, Yamashina A (2010) Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J 74:24-33
28. Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, Emoto M, Nishizawa Y (2010) Brachialankle pulse wave velocity as an index of central arterial stiffness. J Atheroscler Thromb 17:658-665
29. Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC (2004) Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J intern Med 256:308-315
30. Voss P, Siem W (2006) Clinical oxidation parameters of aging. Free Radic Res 40:1339-1349
31. Williams R, LenzEM,Wilson AJ, Granger J,Wilson ID, Major H, Stumpf C, Plumb R (2006) A multi-Analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. Mol Biosyst 2:174-183
32. Wolfram R, Oguogho A, Palumbo B, Sinzinger H (2005) Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8-epi- PGF(2alpha). Eur J Heart Fail 7:167-172
33. Yan S, Wu B, Lin Z, Jin H, Huang J, Yang Y, Zhang X, Shen Z, Zhang W (2009) Metabonomic characterization of aging and investigation on the anti-Aging effects of total flavones of Epimedium. Mol Biosyst 5:1204-1213
34. Zhu Y, Lin JH, Liao HL, Verna L, Stemerman MB (1997) Activation of ICAM-1 promoter by lysophosphatidylcholine: possible involvement of protein tyrosine kinases. Biochim Biophys Acta 1345:93-98
35. Zieman SJ, Melenovsky V, Kass DA (2005) Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25:932-943